首页|期刊导航|检验医学与临床|老年骨质疏松症患者血清caveolin-1、ANXA2、OPG/PYR对脆性骨折的辅助诊断价值

老年骨质疏松症患者血清caveolin-1、ANXA2、OPG/PYR对脆性骨折的辅助诊断价值OA

Adjunctive diagnostic value of serum caveolin-1,ANXA2 and OPG/PYR for fragility fractures in elderly patients with osteoporosis

中文摘要英文摘要

目的 探讨血清小窝蛋白-1(caveolin-1)、膜联蛋白A2(ANXA2)、骨保护素/吡啶啉比值(OPG/PYR)辅助诊断老年骨质疏松症(OP)患者发生脆性骨折的价值.方法 选择2022年1月至2024年1月云南省中医医院收治的206例老年OP患者作为研究对象,根据患者入院时是否发生脆性骨折分为骨折组(100例)和未骨折组(106例).统计2组基线资料、传统骨代谢标志物[Ⅰ型前胶原N端前肽(PⅠNP)、Ⅰ型胶原羧基端肽β特殊序列(β-CTX)、抗酒石酸酸性磷酸酶-5b(TRACP-5b)]、血清caveolin-1、ANXA2水平及 OPG/PYR.采用Pearson相关分析脆性骨折患者血清caveolin-1、ANXA2水平及OPG/PYR与骨密度(BMD)、传统骨代谢标志物的相关性.采用多因素Logistic回归分析老年OP患者发生脆性骨折的影响因素.采用受试者工作特征(ROC)曲线分析血清caveolin-1、ANXA2、OPG/PYR辅助诊断脆性骨折的价值.结果 骨折组腰椎BMD、股骨颈BMD、OPG/PYR及血清PⅠNP、caveolin-1水平低于未骨折组,β-CTX、TRACP-5b、ANXA2水平高于未骨折组,差异均有统计学意义(P<0.05).Pearson相关分析结果显示,脆性骨折患者血清caveo-lin-1水平、OPG/PYR与腰椎BMD、股骨颈BMD、PⅠNP呈正相关(P<0.05),与β-CTX、TRACP-5b呈负相关(P<0.05),ANXA2水平与腰椎BMD、股骨颈BMD、PⅠNP呈负相关(P<0.05),与β-CTX、TRACP-5b呈正相关(P<0.05).多因素Logistic回归分析结果显示,caveolin-1、ANXA2、OPG/PYR、PⅠNP、β-CTX、TRACP-5b均是脆性骨折发生的影响因素(P<0.05).ROC曲线分析结果显示,caveolin-1+ANXA2+OPG/PYR联合辅助诊断脆性骨折的曲线下面积(AUC)为0.943(95%CI:0.900~0.971),与传统标志物联合诊断的AUC比较,差异无统计学意义(Z=1.243,P>0.05).结论 血清ANXA2、caveolin-1、OPG/PYR是老年OP患者发生脆性骨折的独立影响因素,3项联合可作为辅助诊断脆性骨折的指标,并可指导临床决策.

Objective To investigate the adjunctive diagnostic value of serum caveolin-1,annexin A2(ANXA2)and the osteoprotegerin/pyridinoline ratio(OPG/PYR)for fragility fractures in elderly patients with osteoporosis(OP).Methods A total of 206 elderly patients with OP admitted to Yunnan Provincial Hospital of Traditional Chinese Medicine from January 2022 to January 2024 were enrolled.According to the presence of fragility fractures at admission,the patients were assigned to a fracture group(100 cases)and a non-fracture group(106 cases).Baseline characteristics,traditional bone turnover markers[procollagen typeⅠ N-terminal propeptide(PⅠNP),β-carboxy-terminal crosslinked telopeptide of type Ⅰ collagen(β-CTX),tartrateresistant acid phosphatase 5b(TRACP5b)],serum levels of caveolin1 and ANXA2,and the OPG/PYR were recorded and compared between the two groups.Pearson correlation analysis was used to examine the as-sociations of serum caveolin1 and ANXA2 levels and the OPG/PYR with bone mineral density(BMD)and traditional bone turnover markers in patients with fragility fractures.Multivariate Logistic regression analysis was performed to identify factors associated with fragility fractures in elderly patients with OP.Receiver oper-ating characteristic(ROC)curve analysis was conducted to evaluate the adjunctive diagnostic value of serum caveolin1,ANXA2 and OPG/PYR for fragility fractures.Results Lumbar spine BMD,femoral neck BMD,OPG/PYR and serum PⅠNP and caveolin-1 levels were significantly lower in the fracture group than those in the non-fracture group,whereas β-CTX,TRACP-5b and ANXA2 levels were significantly higher,and the differences were statistically significant(P<0.05).Pearson correlation analysis showed that in patients with fragility fractures,serum caveolin-1 level and OPG/PYR were positively correlated with lumbar spine BMD,femoral neck BMD and PⅠNP(P<0.05)and negatively correlated with β-CTX and TRACP-5b(P<0.05);conversely,ANXA2 level was negatively correlated with lumbar spine BMD,femoral neck BMD and PⅠNP(P<0.05),and positively correlated with β-CTX and TRACP-5b(P<0.05).Multivariate Logistic regression analysis indicated that caveolin-1,ANXA2,OPG/PYR,PⅠNP,β-CTX and TRACP-5b were significant factors influencing fragility fractures(P<0.05).ROC curve analysis showed that the combined adjunctive diagnosis using caveolin-1,ANXA2 and OPG/PYR yielded an area of under the curve(AUC)of 0.943(95%CI:0.900-0.971),with no statistically significant difference compared with the AUC of the combined traditional markers(Z=1.243,P>0.05).Conclusion Serum ANXA2,caveolin-1 and the OPG/PYR were established as independent factors for fragility fractures in elderly OP patients.Their combination could yield an adjunc-tive diagnostic tool to inform clinical decision-making.

叶国裕;胡维稳;尹本敬;谢元洋;段星辰;李艺芸;余谨灵;李卓纹;顾海潮

云南省中医医院:骨伤科一病区,云南 昆明 650021云南省中医医院:制剂中心,云南 昆明 650021云南省中医医院:骨伤科四病区,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021云南省中医医院:骨伤科,云南 昆明 650021

医药卫生

骨质疏松症小窝蛋白-1膜联蛋白A2骨保护素/吡啶啉比值脆性骨折老年

osteoporosiscaveolin-1annexin A2osteoprotegerin/pyridinoline ratiofragility fractureelderly

《检验医学与临床》 2026 (6)

835-841,7

云南省卫生健康委员会临床医学中心2022-2024年建设项目(202201AF100958).

10.3969/j.issn.1672-9455.2026.06.019

评论